Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,963 public trials 2,020 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

NCT00049296

Conditions: AIDS-related Kaposi sarcoma, Adenocarcinoma, Anus Diseases, +155 more
Locations: Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia

NCT00002588

Conditions: Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +26 more
Locations: Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Bleomycin in Treating Patients With Non-Hodgkin's Lymphoma

NCT00003110

Conditions: Burkitt Lymphoma, DNA Virus Infections, Dendritic Cell Sarcoma, Interdigitating, +25 more
Locations: Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Molecular Risk Assessment in Planning Treatment for Patients With Non-Hodgkin's Lymphoma

NCT00055640

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Cyclophosphamide W/or W/Out Rituximab and Peripheral Stem Cell Transplantation in Patients With Recurrent Non-Hodgkin's Lymphoma

NCT00028665

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
Locations: Ireland Cancer Center at University Hospitals of Cleveland and Case Western Reserve University Cleveland, Ohio, United States

View Trial Details

Completed

Evaluation of Influenza H1N1 Vaccine in Adults With Lymphoid Malignancies on Chemotherapy

NCT01016548

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +30 more
Locations: Princess Margaret Hospital Toronto, Ontario, Canada

View Trial Details

Completed

Phase I Study of the Proteosome Inhibitor CEP 18770 in Patients With Solid Tumours or Non-Hodgkin's Lymphomas

NCT00572637

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Europen Institute of Oncology Milan, Italy

IOSI - Oncology Institute of Southern Switzerland - Ospedale S. Giovanni Bellinzona, Switzerland

Kantonsspital St. Gallen Sankt Gallen, Switzerland

View Trial Details

Completed

Efficacy Response Duration and Toxicity of Rituximab, Fludarabine, and Cyclophosphamide (RFC) as 1st Line Treatment and Rituximab (R) in Maintenance Treatment in Follicular Non Hodgkin (FNH) Lymphoma

NCT01124526

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Hospital Infanta Cristina Badajoz, Badajoz_Extremadura, Spain

Hospital del Mar Barcelona, Barcelona_ Cataluña, Spain

Instituto Catalán de Oncología (ICO) Barcelona, Barcelona_Cataluña, Spain

Hospital San Pedro de Alcántara Cáceres, Cáceres_Extremadura, Spain

View all 20 locations

View Trial Details

Completed

Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Biological Therapy in Treating Patients With Solid Tumors or Lymphoma

NCT00027937

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +36 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant

NCT00410657

Conditions: Aberrant Motor Behavior in Dementia, Adnexal Diseases, Aggression, +109 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions